Sub-Saharan Africa Pharmaceuticals Market OverviewThe Sub-Saharan Africa (SSA) pharmaceuticals market is emerging as one of the fastest-growing healthcare segments, driven by shifting disease patterns ...
The National on MSN
GPS jamming and cybersecurity quietly loom large at Davos
Technology vulnerabilities abound with stakes higher than ever, says SandboxAQ chief executive ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Our columnist explores the new 'AI continuum' from a developer's perspective, dispels some misconceptions, addresses the skills gap, and offers some practical strategies for marshaling the power of ...
Novartis could lose years of patent protection in the US for its blockbuster multiple sclerosis therapy Gilenya, after a federal appeals verdict went against the company. The litigation revolves ...
SimCity sights.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback